Abstract: A novel maize variety designated 1PLUG57 and seed, plants and plant parts thereof are provided. Methods for producing a maize plant comprise crossing maize variety 1PLUG57 with another maize plant are provided. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 1PLUG57 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby are provided. Hybrid maize seed, plants or plant parts are produced by crossing the variety 1PLUG57 or a locus conversion of 1PLUG57 with another maize variety.

Abstract: A novel maize variety designated X90T899 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X90T899 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X90T899 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X90T899, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X90T899 are provided. Methods for producing maize varieties derived from maize variety X90T899 and methods of using maize variety X90T899 are disclosed.

Abstract: A novel maize variety designated X90V911 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X90V911 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X90V911 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X90V911, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X90V911 are provided. Methods for producing maize varieties derived from maize variety X90V911 and methods of using maize variety X90V911 are disclosed.

Abstract: A novel maize variety designated 1PAKH79 and seed, plants and plant parts thereof are provided. Methods for producing a maize plant comprise crossing maize variety 1PAKH79 with another maize plant are provided. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 1PAKH79 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby are provided. Hybrid maize seed, plants or plant parts are produced by crossing the variety 1PAKH79 or a locus conversion of 1PAKH79 with another maize variety.

Abstract: A stretch-assisting device, adapted for mounting in a vertical orientation on a door, wall or analogous vertical substrate, features an upper framework portion and a lower framework portion, coupled together. Each framework portion consists essentially of hollow rigid tubing arranged in a loop shape, with attached metal rings which project horizontally. Through each plurality of metal rings, an elastic cord is threaded, and joined to form a loop. Once the device is mounted on the substrate, a person can rest a body portion, such as a heel or elbow, on a selected segment of the elastic cord, and begin to stretch a muscle or tendon associated with the body portion. Since the cord is somewhat yielding, triggering of the myotatic reflex is avoided, or at least delayed, thereby facilitating completion of a stretch. A user can also secure an audiovisual playback device adjacent the device, in order to inform the user during stretching.

Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: A stretch-assisting device, adapted for mounting in a vertical orientation on a door, wall or analogous vertical substrate, features an upper framework portion and a lower framework portion, coupled together. Each framework portion consists essentially of hollow rigid tubing arranged in a loop shape, with attached metal rings which project horizontally. Through each plurality of metal rings, an elastic cord is threaded, and joined to form a loop. Once the device is mounted on the substrate, a person can rest a body portion, such as a heel or elbow, on a selected segment of the elastic cord, and begin to stretch a muscle or tendon associated with the body portion. Since the cord is somewhat yielding, triggering of the myotatic reflex is avoided, or at least delayed, thereby facilitating completion of a stretch. A user can also secure an audiovisual playback device adjacent the device, in order to inform the user during stretching.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: A novel maize variety designated X90R983 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X90R983 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X90R983 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X90R983, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X90R983 are provided. Methods for producing maize varieties derived from maize variety X90R983 and methods of using maize variety X90R983 are disclosed.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: A novel maize variety designated X80P537 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X80P537 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X80P537 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X80P537, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X80P537 are provided. Methods for producing maize varieties derived from maize variety X80P537 and methods of using maize variety X80P537 are disclosed.

Abstract: A novel maize variety designated X85R242 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X85R242 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X85R242 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X85R242, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X85R242 are provided. Methods for producing maize varieties derived from maize variety X85R242 and methods of using maize variety X85R242 are disclosed.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides methods of treating taupathies such as Alzheimer's disease with antibodies that bind to human tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.